Peak Pharmaceuticals, Inc.
Limited financial coverage for PKPH.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
Peak Pharmaceuticals, Inc. , an American bio-pharmaceutical and nutraceutical company, specializes in the development, manufacturing, marketing, and sale of therapeutic products derived from hemp extracts. The firm particularly concentrates on formulating over-the-counter, THC-free, hemp-based remedies for human application, designed to help prevent and mitigate symptoms linked to inflammatory and auto-immune conditions.
- CEO
- Jerry Swon
- IPO
- 2014
- Employees
- 1
- HQ
- Scottsdale, AZ, US
Price Chart
- 52W High
- $43.80
- 52W Low
- $1.35
- 50D MA
- $3.20
- 200D MA
- $11.27
- Beta
- 0.56
- Avg Volume
- 483
Get TickerSpark's AI analysis on PKPH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PKPH coverage
Recent articles, reports, and earnings notes.
No research on PKPH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PKPH report →Similar companies
Peers in the same neighborhood.